logo

FDA Calendar

Share
PDUFA dates and FDA Panel Review dates are very important because they are make or break events for biostocks when the decisions are announced. Also, usually biostocks experience a run-up going into the scheduled decision/review dates. So having prior knowledge of the catalysts goes a long way toward maximizing profit or minimizing loss while trading volatile biotech stocks.
Listed below are large cap, mid cap and small cap stocks with pending regulatory catalysts.

Get in-depth analysis and insight on investing in the high-stakes biotech and pharma sectors. Check out our premium biotech research product and our biotech home page.
Company Name
Ticker
Drug
Event
Date
Outcome
Details
ACADIA Pharmaceuticals Inc
NUPLAZID (sNDA)
FDA decision on NUPLAZID for the treatment of hallucinations and delusions associated with dementia-related psychosis
04/03/2021
AVEO Pharmaceuticals, Inc.
Tivozanib (NDA)
FDA decision on Tivozanib treatment for relapsed or refractory renal cell carcinoma
03/31/2021
Merck & Co Inc.
KEYTRUDA (sBLA)
FDA decision on KEYTRUDA for Patients with High-Risk Early-Stage triple-negative breast cancer Based on KEYNOTE-522 Trial
03/29/2021
Bristol-Myers Squibb Co.
Idecabtagene vicleucel (BLA)
FDA decision on Idecabtagene vicleucel for treatment of adult patients with relapsed and refractory myeloma
03/27/2021
bluebird bio Inc.
Idecabtagene vicleucel (BLA)
FDA decision on Idecabtagene vicleucel for treatment of adult patients with relapsed and refractory myeloma
03/27/2021
CytRx Corp.
Arimoclomol (NDA)
FDA decision on Arimoclomol for the treatment of Niemann-Pick disease Type C
03/17/2021
Biogen Inc.
Aducanumab (BLA)
FDA decision on Aducanumab for Alzheimer's Disease
03/07/2021
KEMPHARM, INC
KMPH.OB
KP415 (NDA)
FDA decision on KP415 for the treatment of attention deficit hyperactivity disorder
03/02/2021
Blueprint Medicines
Pralsetinib (NDA)
FDA decision on Pralsetinib for the treatment of advanced or metastatic RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer
02/28/2021
CorMedix Inc.
Defencath (NDA)
FDA decision on Defencath for the prevention of catheter related blood stream infections
02/28/2021
Athenex, Inc.
Oral Paclitaxel in combination with Encequidar (NDA)
FDA decision on Oral Paclitaxel in combination with Encequidar for the treatment of Metastatic Breast Cancer
02/28/2021
Sarepta Therapeutics
Casimersen (NDA)
FDA decision on Casimersen for DMD amenable to Exon 45 skipping
02/25/2021
Bristol-Myers Squibb Co.
OPDIVO (sBLA)
FDA decision on OPDIVO in combination with CABOMETYX for patients with advanced renal cell carcinom
02/20/2021
Exelixis, Inc.
CABOMETYX (sNDA)
FDA decision on OPDIVO in combination with CABOMETYX for patients with advanced renal cell carcinom
02/20/2021
TG Therapeutics Inc.
TGTX, TGTX.OB
Umbralisib (NDA)
FDA decision on Umbralisib as a treatment for for patients with previously treated marginal zone lymphoma
02/15/2021

ALSO READ - COVID-19 Drugs In Development Calendar which lists Companies that are in Race to find a Treatment or Vaccine for the Novel Coronavirus.

Buy this Content


stockmarkets jan11 21oct20 What's moving these stocks in the pre-market hours today?
stockmarkets jan18 20oct20 What's moving these stocks in the pre-market hours today?
biotech oct20 Today's Daily Dose brings you news about AbbVie seeking expanded approval of RINVOQ in atopic dermatitis, Aptinyx's positive results in post-traumatic stress disorder trial, Endo International acquiring BioSpecifics Technologies, the merger agreement between Cleveland BioLabs and privately-held Cytocom, and the licensing agreement offer of Liquidia.
Read More
Vivo Cannabis Inc. said it will cut about 18 percent of its workforce and sell non-core assets as part of its efforts to reduce costs and achieve positive operating cash flow. The Canadian cannabis company also announced changes to its leadership team. Vivo said it will eliminate about 18 percent...
Missouri has launched medical marijuana sales in the state, with the first licensed marijuana dispensaries opening over the weekend in St. Louis County. The Missouri Department of Health and Senior Services or DHSS said on Saturday that the first legal sales of medical marijuana in Missouri occurred...
Even as COVID-19 pandemic continues to surge in majority of U.S. states, a lower infection and death rate was recorded nationally in the last 24 hours. With 48,210 new cases reporting, the national total increased to 8155592, as per Johns Hopkins University's latest data. With 388 deaths reported nationally, the total number of COVID casualties in the U.S. increased to 219676. The outbreak is
Read More